Importantly, the DARS-AS1/miR-330-3p/NAT10 axis may help to develop novel prognosis biomarkers and treatment strategies, which may provide a new hint for comprehending the mechanism of gastric cancer progression. Here, NAT10 is linked to gastric cancer.